Notice 20 May 2025 drug enforcement, controlled substances, research, import regulations, healthcare, compliance

⚗️Usona Institute Seeks Registration to Import Controlled Substances

Usona Institute. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 14 May 2025 controlled substances, life sciences, drug enforcement, regulatory compliance, usa, pall life sciences

💊Pall Life Sciences Applies for Controlled Substances Import Registration

Pall Life Sciences PR, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 14 May 2025 controlled substances, drug enforcement, business operations, regulatory compliance, pharmaceutical industry

📦DEA Notice

Research Triangle Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 7 May 2025 medical regulation, healthcare, compliance, prescription violations, drug enforcement, arizona, dea

⚖️DEA Registration Revocation for Prescription Violations

The Drug Enforcement Administration (DEA) issued a decision revoking a medical doctor's registration due to issuing controlled substance prescriptions without state authority, violating both federal and state law. The order underscores the importance of compliance with healthcare regulations to safeguard public health and safety.

Learn More
Notice 7 May 2025 physician, medical regulation, controlled substances, compliance, california, drug enforcement, dea

⚖️DEA Revokes Registration for Dr. Edmund Ayoub Jr. Due to Compliance Issues

The Drug Enforcement Administration has revoked the registration of Dr. Edmund Ayoub Jr. due to his cessation of authority to practice medicine in California, a prerequisite for handling controlled substances. The ruling highlights the implications of regulatory compliance for medical practitioners and their business operations in the healthcare sector.

Learn More
Notice 7 May 2025 healthcare regulation, compliance, drug enforcement, dea, opioids

⚖️DEA Revokes Registration for Improper Controlled Substance Prescribing

The Drug Enforcement Administration (DEA) issued a revocation order for Margaret Dennis, D.M.D., for improper prescribing of controlled substances, citing numerous violations of federal and state laws. The findings include lack of medical justification, inadequate record-keeping, and failure to monitor potential abuse, highlighting significant compliance issues within the healthcare sector.

Learn More
Notice 1 May 2025 dea, drug enforcement, regulatory compliance, controlled substances, pharmaceutical industry

💊Importer of Controlled Substances Application by US Pharmacopeial Convention

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 1 May 2025 drug enforcement, regulatory compliance, controlled substances, business applications, pharmaceuticals

💊DEA Notice on Importer Application for Controlled Substances

Unither Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 controlled substances, regulatory, business registration, compliance, drug enforcement

⚖️VHG Labs Controlled Substances Import Application Overview

VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 controlled substances, pharmaceutical industry, compliance, clinical trials, drug enforcement

💊Almac Clinical Services' Importer Application for Controlled Substances

Almac Clinical Services, Inc., (ACSI) has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More